docrishabhsingh's profile picture. Heme/Onc Fellow PGY-4 @IUHemOnc | IM via @UICOMPeoria| MBBS @NairTnmc | @HTRSfellows Council 2024-2026 | Passionate about #ClassicalHeme🩸| He/Him/His |

Rishabh Singh, MD 🩸

@docrishabhsingh

Heme/Onc Fellow PGY-4 @IUHemOnc | IM via @UICOMPeoria| MBBS @NairTnmc | @HTRSfellows Council 2024-2026 | Passionate about #ClassicalHeme🩸| He/Him/His |

Rishabh Singh, MD 🩸 đã đăng lại

The world needs this treatment. Really exciting preclinical work in @BloodPortfolio on a bispecific nanobody that links VWF to albumin to increase VWF levels and reduced bleeding. There's also an editorial from world expert on VWD, James O'Donnell

richardbuka's tweet image. The world needs this treatment. Really exciting preclinical work in @BloodPortfolio on a bispecific nanobody that links VWF to albumin to increase VWF levels and reduced bleeding. 

There's also an editorial from world expert on VWD, James O'Donnell

Rishabh Singh, MD 🩸 đã đăng lại

New episode of “Don’t Just Read the Abstract” out now! In Episode 25, @PipNicolson & I discuss the BASIS trial of the TFPI inhibitor marstacimab in severe haemophilia A/B. Lots of critical appraisal points, including trial ethics and the Hawthorne effect. Great, digestible CPD!

richardbuka's tweet image. New episode of “Don’t Just Read the Abstract” out now! In Episode 25, @PipNicolson & I discuss the BASIS trial of the TFPI inhibitor marstacimab in severe haemophilia A/B. 

Lots of critical appraisal points, including trial ethics and the Hawthorne effect. Great, digestible CPD!

Rishabh Singh, MD 🩸 đã đăng lại

Amazing work from my friend Stephen Hibbs in @BloodPortfolio along with an allstar international cast - defining reference neutrophil ranges in Duffy null. Vital work to fight against systematic discrimination of ppl with Duffy null in cancer care & research among others.

richardbuka's tweet image. Amazing work from my friend Stephen Hibbs in @BloodPortfolio along with an allstar international cast - defining reference neutrophil ranges in Duffy null. Vital work to fight against systematic discrimination of ppl with Duffy null in cancer care & research among others.
richardbuka's tweet image. Amazing work from my friend Stephen Hibbs in @BloodPortfolio along with an allstar international cast - defining reference neutrophil ranges in Duffy null. Vital work to fight against systematic discrimination of ppl with Duffy null in cancer care & research among others.

I dream of a day when we can predict and prevent every clot!


Rishabh Singh, MD 🩸 đã đăng lại

Prolonged PT/PTT in cyanotic heart disease often calls for a heme consult. However, it is important to recognize that due to high hematocrit, often above 65% leads to less plasma in the tube causing altered plasma-anticoagulant ratio in the blue top tube and falsely high PT/PTT.


These tables should be in our (and everyone's) fellow survival guide @IUHemOnc!

Announcing the MAGIC-ONC guidelines for the placement and management of vascular access devices in patients with cancer, including specific recommendations for both hematologic and solid tumor malignancies. #MAGICOnc #onctwitter acpjournals.org/doi/epdf/10.73…



Rishabh Singh, MD 🩸 đã đăng lại

The scientific articles that end up published are the tip of an iceberg of hard work. This includes the dedication of selfless reviewers who sacrifice precious time to promote good science. To those that agree to review, with passion & care: Thanks. You make the world better.


Rishabh Singh, MD 🩸 đã đăng lại

H-1B visa–sponsored physicians are twice as prevalent in rural counties and nearly 4 times as common in high-poverty areas, highlighting the potential harm of rising visa costs to health care access. ja.ma/47xKm6F

JAMA_current's tweet image. H-1B visa–sponsored physicians are twice as prevalent in rural counties and nearly 4 times as common in high-poverty areas, highlighting the potential harm of rising visa costs to health care access. 

ja.ma/47xKm6F

Rishabh Singh, MD 🩸 đã đăng lại

Today in @NEJM_AI : Chris Mansi and I lay out our vision for redesigning clinical workflows with Generative AI. We build on our decade of work across 1,800 hospitals and use our chart summarization tool (Viz Assist) as one illustrative example for a path forward. "We have both…

AndrewMIbrahim's tweet image. Today in @NEJM_AI : Chris Mansi and I lay out our vision for redesigning clinical workflows with Generative AI. We build on our decade of work across 1,800 hospitals and use our chart summarization tool (Viz Assist) as one illustrative example for a path forward. 

"We have both…

Loading...

Something went wrong.


Something went wrong.